Abstract

Suberoylanilide hydroxamic acid (SAHA) is a histone deacetylase inhibitor, which has been widely utilized throughout the cancer research field. SAHA-induced radiosensitization in normal human fibroblasts AG1522 and lung carcinoma cells A549 were evaluated with a combination of γ-rays, proton, and carbon ion exposure. Growth delay was observed in both cell lines during SAHA treatment; 2 μM SAHA treatment decreased clonogenicity and induced cell cycle block in G1 phase but 0.2 μM SAHA treatment did not show either of them. Low LET (Linear Energy Transfer) irradiated A549 cells showed radiosensitization effects on cell killing in cycling and G1 phase with 0.2 or 2 μM SAHA pretreatment. In contrast, minimal sensitization was observed in normal human cells after low and high LET radiation exposure. The potentially lethal damage repair was not affected by SAHA treatment. SAHA treatment reduced the rate of γ-H2AX foci disappearance and suppressed RAD51 and RPA (Replication Protein A) focus formation. Suppression of DNA double strand break repair by SAHA did not result in the differences of SAHA-induced radiosensitization between human cancer cells and normal cells. In conclusion, our results suggest SAHA treatment will sensitize cancer cells to low and high LET radiation with minimum effects to normal cells.

Highlights

  • Radiosensitizers can be beneficial for radiation therapy via increasing cell killing [1]

  • We have investigated the selective sensitization with suberovlanilide hydroxamic acid (SAHA) treatment in cancer cells versus normal cells

  • Log growing cells were exposed to different concentrations of SAHA (0.2–4 μM)

Read more

Summary

Introduction

Radiosensitizers can be beneficial for radiation therapy via increasing cell killing [1]. It is important to search clinically approved anti-cancer drugs for novel radiosensitizing effects to avoid complications during drug trials. One pathway identified in these publications was the homologous recombination repair pathway [11,12,13,14], and another pathway was non-homologous end joining repair through Ku70 and 86 [15,16]. These DNA repair inhibitory effects by HDACi were combined with photon ionizing radiation and chemotherapeutic agents, and showed synergistic effects for cell killing. A combination of HDACi with particle radiation, including proton and carbon ion, are still limited [17,18,19,20]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.